NCT03649711View on ClinicalTrials.gov

Chronic Kidney Disease (CKD) Platelet Study

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

September 2, 2021

Study Completion Date

September 2, 2021

Conditions
Chronic Kidney DiseasesHeart AttackStroke, Ischemic
Interventions
DRUG

Ticagrelor 90mg

Ticagrelor Pill

DRUG

Clopidogrel 75mg

Clopidogrel Pill and a matching placebo to conceal frequency

DRUG

Aspirin 81 mg

Aspirin Pill

Trial Locations (2)

72205

Central Arkansas Veterans Affairs Hospital, Little Rock

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

American Society of Nephrology

OTHER

lead

University of Arkansas

OTHER

NCT03649711 - Chronic Kidney Disease (CKD) Platelet Study | Biotech Hunter | Biotech Hunter